Revenue continues to grow strongly

Rua Bioscience Limited (“RUA”) is pleased to report continued month-on-month growth in sales revenue, as seen in our latest figures below (unaudited). With our products now available in three key markets - Aotearoa NZ, Australia and Germany - Rua is establishing a strong national and international presence.

Apr24 - $6,000
May24 - $16,000
Jun24 - $23,000
Jul24 - $24,000
Aug24 - $82,000
Sep24 - $122,000
Oct24 - $128,000

Looking ahead, we are launching products in the UK within the next month, a move that we anticipate will further accelerate our strong growth trajectory. And we will also have new products in Aotearoa New Zealand and Germany before the end of this year.

Our current revenue trajectory along with new product offerings in key markets give us confidence in our business plan. We are forecasting revenue over $3mill by the end of FY25.

ENDS  
 
The person who authorised this announcement:

Paul Naske
Chief Executive Officer
[email protected]
+64 21 445154

---

Announcement PDF